Chun‐Ming Tsai

11.8k citations
114 papers · 7.8k indexed · 4 hit papers · h-index 31
Topics
Lung Cancer Treatments and Mutations (89 papers)Lung Cancer Research Studies (48 papers)Lung Cancer Diagnosis and Treatment (37 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE

In The Last Decade

Chun‐Ming Tsai

111 papers receiving 7.7k citations

Hit Papers

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed ...2013202620172021201320142016201350010001.5k2.0k

Peers

Chun‐Ming Tsai
Comparison fields: 5 of 121
  • Pulmonary and Respiratory Medicine 6.4k
  • Oncology 5.3k
  • Molecular Biology 2.0k
  • Cancer Research 1.4k
  • Surgery 417
Replace David M. Jackman with:
David M. Jackman United States
Ki Hyeong Lee South Korea
José Rodrigues Pereira Brazil
Eng Huat Tan Singapore
Takashi Seto Japan
Alessandro Morabito Italy
Renato Martins United States
Akira Inoue Japan
Mircea Dediu Romania
Margarita Majem Spain
Chun‐Ming Tsai relative to David M. Jackman United States David M. Jackman's profile →
Citations per field
00.5×1.5×
David M. Jackman · 1×
Citations per year

Countries citing papers authored by Chun‐Ming Tsai

Since Specialization
Citations

This map shows the geographic impact of Chun‐Ming Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Ming Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Ming Tsai more than expected).

Fields of papers citing papers by Chun‐Ming Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Ming Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Ming Tsai. The network helps show where Chun‐Ming Tsai may publish in the future.

Co-authorship network of co-authors of Chun‐Ming Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Ming Tsai. A scholar is included among the top collaborators of Chun‐Ming Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Ming Tsai. Chun‐Ming Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3 9
4 3
5 8
6 2
7 4
8 4
9 13
10
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutationsbreakdown →
2461
11 41
12 16
13 1
14 32
15 31
16 6
17 26
18
Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
74
19 3
20 10

About Chun‐Ming Tsai

Chun‐Ming Tsai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 114 papers that have together received 7.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (89 papers), Lung Cancer Research Studies (48 papers) and Lung Cancer Diagnosis and Treatment (37 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.4k citations), Oncology (5.3k citations) and Cancer Research (1.4k citations). Chun‐Ming Tsai has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include James Chih‐Hsin Yang, Vera Hirsh, Tony Mok, Sumitra Thongprasert, Lecia V. Sequist, Wu‐Chou Su, Joseph S. K. Au, Sarayut Lucien Geater, Michael Boyer and Martin Schüler. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026